Orrick Advises AXA Investment Managers on Acquisition of Majority Stake in German Laboratory Group Amedes

August.02.2021

Orrick advised AXA IM Real Assets, as part of a buying consortium that also includes OMERS and GS Infrastructure, in the acquisition of German laboratory group Amedes from French infrastructure investor Antin. Amedes operates laboratories at 90 sites in Germany, Belgium, Austria and Dubai, employing about 4,000 staff and treating 450,000 patients a year.

The Orrick team was led by partner Patrick Tardivy and included partner Olivier Jouffroy and associate Lara Donnedieu De Vabres for the M&A aspects and partner Patrick Hubert and associate Lena Boucon for the competition law aspects of the transaction.